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Biochemift R ival Infirmary, Preston, Lancashire Phosphatases are enzymes capable of catalysing the hydrolysis of phosphoric esters with liberation 'of inorganic phosphate, they are found widely spread throughout nature. The early work on the discovery and properties of these enzymes has been thoroughly reviewed by Kay (1932) .
Acid and Alkaline Phosphatases
There are probably many different phosphatases present in living organisms and much valuable data is being accumulated on their identity and methods of differential estimation. In the present state of our knowledge, however, and from the aspect of clinical application, we can best think of them in terms of two groups, the socalled' alkaline ' and' acid' phosphatases. These enzymes are distinguished by the fact that the first class are optimally active at an alkaline and the second at an acid pH. The actual pH varies with the particular substrate, but when phenyl phosphate is used, the acid phosphatases have an optimum pH of 4.9 and the alkaline phosphatases are optimally active at pH 9.8. Since these pH values are sufficiently far apart, it is possible to determine one of the two groups of phosphatase in the presence of the other. It will be convenient in the first place to consider the two groups of phosphatases separately. Alkaline Phosphatases
The foundation of our knowledge of the biological functions of the alkaline phosphatases was laid by Robison (1923) when he found an enzyme present in the ossifying cartilage of young rats and rabbits which liberated inorganic phosphate from hexose phosphate. This enzyme was op.-timally active at a pH 9.--9.5 under the conditions used by him. Robison suggested that alkaline phosphatase played a vital part in ossification, since enzymic hydrolysis of the phosphoric esters present in the fluids bathing the bone or cartilage led to a local increase in the concentration of inorganic phosphate in solution and thus to deposition of bone salt. Following up this observation, Robison, Macleod and Rosenheim (1930) stated that their results ' set in sharp distinction two mechanisms in calcifying hypertrophic cartilage, (i) the phosphatase mechanism which produces in the matrix fluid a condition of supersaturation with respect to bone salts, and (2) the inorganic mechanism which favours deposition of this salt from supersaturation.'
In the meantime, Martland, Hansman and Robison (1924) had demonstrated the presence of alkaline phosphatase in blood plasma, and Kay (1929) found raised levels in patients suffering from osteitis deformans (Paget's disease) and osteitis fibrosa cystica (Von Recklinghausen's disease). Kay suggested that raised plasma phosphatase levels might be due to leakage from the bones, where the enzyme had been produced in excess to compensate for the bone lesion, or might result from the bending of the weakened bones which squeezed out some of the cellular contents. Increased plasma alkaline phosphatase levels were also found in rickets (Demuth, 1925) , cancer metastases in the bones (Coryn, 1934) and in jaundice (Roberts, 1930 (Bodansky, 1933) Gutman and Gutman (1938) It is not so easy, however, to see why, in conditions such as Paget's disease, where a marked increase in alkaline phosphatase occurs, there may also be an increase in acid phosphatase. The first hypothesis to be investigated was that the alkaline enzyme was not completely inactivated at pH 4.9, and that consequently some hydrolysis could take place at this pH. Such hydrolysis, although due to the activity of the alkaline enzyme, would, of course, be recorded as due to a different enzyme, namely acid phosphatase. This was found by Gutman, Gutman and Robinson (1940) Employing the alcohol technique to which reference has already been made, Herbert found that the addition of alcohol to sera in the nonprostatic diseases usually led to no significant change in the serum acid phosphatase concentration, although sometimes it caused a definite rise, and sometimes a slight fall. From 0o2 cases of non-prostatic disease, there were only two exceptions to the rule that alcohol treatment does not cause a fall of more than one unit in the enzyme level. All the 14 cases of non-prostatic disease found to have total serum acid phosphatase concentrations greater than 5 units per ioo ml. conformed to this rule. In five of the cases of prostatic cancer in which bone metastases were not demonstrated, or where there was no radiological examination, a significant fall occurred after alcohol treatment, despite the fact that the total acid These workers found that their formalin procedure, despite occasional failures, was of clinical help in distinguishing between prostatic cancer and other diseases. In the high figure for bronchopneumonia quoted above, for example, the value after treatment with formalin was only i.8 units per ioo ml., thus indicating that the high serum phosphatase value found originally was due to acid phosphatases other than that from the prostate. In the figures given in Table 2 and  Table 3 for the formalin procedure, the upper limit of normal is taken as 4 units per ioo ml. Only seven out of 57 cases in Abul-Fadl and King's general miscellaneous group gave results greater than 3 units per ioo ml. after treatment with formalin; the highest figure (6.6 units per IOO ml.) being found in a case of steatorrhoea with total acid phosphatase I2 units and associated raised serum alkaline phosphatase (48 KingArmstrong units per ioo ml.). Of the seven raised serum formalin resistant acid phosphatase values, only five were greater than 4.0 units per ioo ml.
In the 22 cases of prostatic cancer with demonstrable metastases i6 (that is all the cases with original high total acid phosphatase) showed serum formalin resistant enzyme greater than 4 units per ioo ml.
The value of formalin, in distinguishing raised serum acid phosphatase due to the prostatic enzyme from those where the enzyme originates elsewhere, has been confirmed independently by one of us (G.E.D.) in a series not yet sufficiently comprehensive for publication.
Abul-Fadl and King also tried Herbert's alcohol procedure in a large number of their cases. Their findings showed that falls in serum acid phosphatase concentration after alcohol treatment occurred more frequently, and to a greater degree in prostatic cancer than in other conditions. The fall in these other conditions was, however, very often much greater than i.o units per ioo ml. (the figure given by Herbert) and occasionally greater than 2.0 units per ioo ml.
In the I5 cases of untreated prostatic cancer with bone metastases studied by the alcohol technique, and where the serum total acid phosphatase level was raised, the fall on alcohol treatment was greater than 7 units per ioo ml. in 14 cases, while in the other case it was I.4 units per I00 ml. Among the cases of this condition, when the serum acid phosphatase was not originally raised, the fall was 3.8 and i.i respectively in two (1942) HERBERT ( (b) Acid phosphatase In assessing the value of acid phosphatase estimations in prostatic cancer, two things must be established. Firstly, the constancy with which raised values are encountered in prostatic cancer, and secondly, the frequency with which such values are found in other conditions. These two questions will be considered separately. It is generally agreed that raised serum acid phos-.
phatase values are found in m-isb`Wifitall, cases of carcinoma of the prostate with bone metastases. As Sullivan, et al. point out, excluding the possibility of errors in diagnosis or in the chemical estimation, there are three other possible causes of failure which have to be considered, (i) the extent of the invasion of blood and lymph channels in a particular case may not be sufficiently great to allow large amounts of the prostatic enzyme to pass into the blood stream, (2) the neoplastic prostate tissue, in some patients, may produce small quantities of acid phosphatase and (3) the serum enzyme level may have been lowered by treatment.
Sullivan found that some (but not all) of the cases in which normal serum acid phosphatase values were found were in patients with markedly anaplastic tumours, and in one case, the tumour itself was found to show very little enzyme activity. Herbert also found the tumour to be anaplastic in one of her cases with bone metastases, in which a normal serum acid phosphatase value was obtained.
So far as the serum acid phosphatase concentration in diseases other than prostatic cancer with metastases is concerned, the work of Abul-Fadl and King suggests that marked increases may be found more frequently than has been thought hitherto. Such increases are, however, often due to an acid phosphatase'which may be distinguished from prostatic phosphatase by the use of substances which inactiyate the various enzymes in a different degree. The stimulus which the introduction of alcohol and formalin has given will, undoubtedly, lead to further advances in our knowledge of this subject. Apart from inactivation experiments, clinical findings may also be of value in deciding whether an increased serum acid phosphatase concentration is from a non-prostatic source.
All workers are agreed with the statements of Sullivan, et al. on the place of serum acid phosphatase estimations in the diagnosis of metastasizing prostatic cancer. The main value is in those patients suspected on clinical grounds, and from X-ray evidence, of metastasizing prostatic cancer, and where confirmation is sought. When the X-ray findings are inconclusive, the diagnosis may be established by the phosphatase estimation, and it is often possible to anticipate the X-ray demonstration of bone metastases by several months. Conversely, where the presence of metastases is definitely established, evidence may be obtained for or against the possibility that the primary tumour is in the prostate where this is in doubt. The estimation is also helpful in following the course of therapy.
(c) Acid and alkaline phosphatase 
